Preimplantation Genetics Diagnosis Market is Growing With Promising Value of USD 92.0 Billion by 2030 | Agilent Technologies, Inc., CeGaT GmbH, Illumina Inc., Illumina Inc., Invitae Corporation

As per the report published by Allied Market Research, the global Preimplantation Genetics Diagnosis (PGD) Market was accounted for $81.52 billion in 2020, and is estimated to reach $217.19 billion by 2030, growing at a CAGR of 10.4% from 2021 to 2030.

Request Sample Copy of the Report:

https://www.alliedmarketresearch.com/request-sample/1470

Key Takeaways:

Growing Demand for Healthy Offspring: The primary driver of the PGD market is the increasing demand from couples who are carriers of genetic diseases or have a family history of genetic disorders. These couples seek to reduce the risk of passing on such conditions to their children.

Advancements in Genetic Testing Technologies: The PGD market benefits from ongoing advancements in genetic testing technologies. These include techniques such as polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), and next-generation sequencing (NGS), which enable the detection of a wide range of genetic abnormalities.

Expanding Range of Tested Conditions: Initially, PGD was used for single-gene disorders, such as cystic fibrosis and sickle cell anemia. However, the scope of PGD has expanded to include screening for chromosomal abnormalities like Down syndrome and sex-linked disorders, along with broader genetic panels.

Market Segmentation:

By Genetic Condition:

Single-Gene Disorders: These are genetic disorders caused by mutations in a single gene, such as cystic fibrosis, sickle cell anemia, and Tay-Sachs disease.

Chromosomal Abnormalities: Conditions caused by changes in the number or structure of chromosomes, including Down syndrome, Turner syndrome, and Klinefelter syndrome.

Sex-Linked Disorders: Genetic conditions that are linked to the sex chromosomes, such as hemophilia and Duchenne muscular dystrophy.

By Technology:

Polymerase Chain Reaction (PCR): A technique used to amplify DNA for analysis, particularly suitable for detecting single-gene disorders.

Fluorescence In Situ Hybridization (FISH): A method to visualize and map the genetic material in an individual's cells, often used to identify chromosomal abnormalities.

By End User:

Fertility Clinics: Medical centers specializing in assisted reproductive technologies, where PGD is performed as part of IVF procedures.

Genetic Testing Laboratories: Facilities that specialize in genetic testing services, including PGD testing.

By Geography:

Asia-Pacific (China, Japan, India, South Korea, Rest Of Asia Pacific)
LAMEA (Latin America, Middle East, Africa)
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Rest of Europe)

Request for Customization -

https://www.alliedmarketresearch.com/request-for-customization/1470

Regional Growth Dynamics:

For instance, according to the U.S. Department of Health & Human Services, as of 2019, there are 489 fertility clinics in the U.S. that are involved in providing ART solutions. States including Massachusetts, Columbia, and New Jersey have the highest proportion of ART births. In addition, increase in awareness regarding healthy embryos in developing countries is expected to be a preimplantation genetic diagnosis market opportunity.

Competitive Landscape:

Agilent Technologies, Inc.
CeGaT GmbH
Illumina Inc., Illumina Inc.
Invitae Corporation
Laboratory Corporation of America Holdings
Natera Inc.
PacGenomics
PerkinElmer, Inc.
Quest Diagnostics Inc.
Reproductive Genetic Innovations (RGI)

Buy this Premium Research Report:

https://www.alliedmarketresearch.com/purchase-enquiry/1470

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Contact Details:

David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.